# Bayer (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/bayer-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 27.3 |
| Citations | 1,095,589 |
| City | Whippany |
| Country | US |
| Description | Bayer (United States) is a research organisation in Whippany, US. OpenAlex records 8,509 works and 1,095,589 citations for it. 2,638 researchers list it as their most recent affiliation. |
| Homepage | http://www.bayer.us/ |
| OpenAlex ID | https://openalex.org/I150569930 |
| Region | New Jersey |
| Researchers | 2,638 |
| ROR ID | https://ror.org/034ffbg36 |
| Type | company |
| Works | 8,509 |

## University papers

Showing 12 of 56.

- [Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis](https://scholariq.org/papers/global-prevalence-of-chronic-kidney-disease-a-systematic-review-and-meta/)
- [Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effect-of-finerenone-on-chronic-kidney-disease-outcomes-in-type-2-diabetes/)
- [Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis](https://scholariq.org/papers/cardiovascular-and-kidney-outcomes-with-finerenone-in-patients-with-type-2/)
- [Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics](https://scholariq.org/papers/lymphatic-metastasis-in-the-absence-of-functional-intratumor-lymphatics/)
- [Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?](https://scholariq.org/papers/use-of-cost-effectiveness-analysis-in-health-care-resource-allocation-decision/)
- [Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/finerenone-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/)
- [Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy](https://scholariq.org/papers/effect-of-finerenone-on-albuminuria-in-patients-with-diabetic-nephropathy/)
- [Molecular mechanisms and therapeutic targets for diabetic kidney disease](https://scholariq.org/papers/molecular-mechanisms-and-therapeutic-targets-for-diabetic-kidney-disease/)
- [Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex](https://scholariq.org/papers/molecular-cloning-and-characterization-of-a-second-subunit-of-the-interleukin-1/)
- [Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine](https://scholariq.org/papers/steroidal-and-non-steroidal-mineralocorticoid-receptor-antagonists-in/)
- [Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial](https://scholariq.org/papers/safety-and-tolerability-of-the-novel-non-steroidal-mineralocorticoid-receptor/)
- [A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease](https://scholariq.org/papers/a-randomized-controlled-study-of-finerenone-vs-eplerenone-in-patients-with/)

## University researchers

- [Peter Kolkhof](https://scholariq.org/researchers/peter-kolkhof/)
- [Samuel Fatoba](https://scholariq.org/researchers/samuel-fatoba/)
- [Sheldon X. Kong](https://scholariq.org/researchers/sheldon-x-kong/)
- [Scott Greenfeder](https://scholariq.org/researchers/scott-greenfeder/)
- [Jihong Zong](https://scholariq.org/researchers/jihong-zong/)

## University top topics

Showing 8 of 25.

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.